Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Journal of Clinical Orthopaedics and Trauma
|
February 2, 2019
The 'John Thomas' sign and pelvic fractures-Fact or humorous myth?: A systematic review and meta-analysis
Louis Gerber, Abdullah E Laher, Callistus O A Enyuma, et al.
Emergency Radiology
|
January 17, 2018
The ultrasonographic "whirlpool sign" in testicular torsion: valuable tool or waste of valuable time? A systematic review and meta-analysis
Jared McDowall, Ahmed Adam, Louis Gerber, et al.
The Journal of Biological Chemistry
|
June 26, 2012
Reactivation of mitogen-activated protein kinase (MAPK) pathway by FGF receptor 3 (FGFR3)/Ras mediates resistance to vemurafenib in human B-RAF V600E mutant melanoma
Vipin Yadav, Xiaoyi Zhang, Jiangang Liu, et al.
Frontiers in Behavioral Neuroscience
|
June 13, 2022
Precise Quantification of Behavioral Individuality From 80 Million Decisions Across 183,000 Flies
Benjamin de Bivort, Sean Buchanan, Kyobi Skutt-Kakaria, et al.
Oncotarget
|
October 21, 2017
Preclinical characterization of abemaciclib in hormone receptor positive breast cancer
Raquel Torres-Guzmán, Bruna Calsina, Ana Hermoso, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 28, 2008
SGX393 inhibits the CML mutant Bcr-AblT315I and preempts in vitro resistance when combined with nilotinib or dasatinib
Thomas O'Hare, Christopher A Eide, Jeffrey W Tyner, et al.
Plos One
|
May 31, 2014
Identification of druggable cancer driver genes amplified across TCGA datasets
Ying Chen, Jeremy McGee, Xianming Chen, et al.
Cancer Discovery
|
January 7, 2016
Oncogenic BRAF Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120
Shih-Hsun Chen, Youyan Zhang, Robert D Van Horn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2018
Abemaciclib Is Active in Preclinical Models of Ewing Sarcoma via Multipronged Regulation of Cell Cycle, DNA Methylation, and Interferon Pathway Signaling
Michele Dowless, Caitlin D Lowery, Terry Shackleford, et al.
Molecular Cancer Therapeutics
|
October 22, 2017
Discovery of a Highly Selective NAMPT Inhibitor That Demonstrates Robust Efficacy and Improved Retinal Toxicity with Nicotinic Acid Coadministration
Genshi Zhao, Colin F Green, Yu-Hua Hui, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Journal of Clinical Orthopaedics and Trauma
|
February 2, 2019
The 'John Thomas' sign and pelvic fractures-Fact or humorous myth?: A systematic review and meta-analysis
Louis Gerber, Abdullah E Laher, Callistus O A Enyuma, et al.
Emergency Radiology
|
January 17, 2018
The ultrasonographic "whirlpool sign" in testicular torsion: valuable tool or waste of valuable time? A systematic review and meta-analysis
Jared McDowall, Ahmed Adam, Louis Gerber, et al.
The Journal of Biological Chemistry
|
June 26, 2012
Reactivation of mitogen-activated protein kinase (MAPK) pathway by FGF receptor 3 (FGFR3)/Ras mediates resistance to vemurafenib in human B-RAF V600E mutant melanoma
Vipin Yadav, Xiaoyi Zhang, Jiangang Liu, et al.
Frontiers in Behavioral Neuroscience
|
June 13, 2022
Precise Quantification of Behavioral Individuality From 80 Million Decisions Across 183,000 Flies
Benjamin de Bivort, Sean Buchanan, Kyobi Skutt-Kakaria, et al.
Oncotarget
|
October 21, 2017
Preclinical characterization of abemaciclib in hormone receptor positive breast cancer
Raquel Torres-Guzmán, Bruna Calsina, Ana Hermoso, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 28, 2008
SGX393 inhibits the CML mutant Bcr-AblT315I and preempts in vitro resistance when combined with nilotinib or dasatinib
Thomas O'Hare, Christopher A Eide, Jeffrey W Tyner, et al.
Plos One
|
May 31, 2014
Identification of druggable cancer driver genes amplified across TCGA datasets
Ying Chen, Jeremy McGee, Xianming Chen, et al.
Cancer Discovery
|
January 7, 2016
Oncogenic BRAF Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120
Shih-Hsun Chen, Youyan Zhang, Robert D Van Horn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2018
Abemaciclib Is Active in Preclinical Models of Ewing Sarcoma via Multipronged Regulation of Cell Cycle, DNA Methylation, and Interferon Pathway Signaling
Michele Dowless, Caitlin D Lowery, Terry Shackleford, et al.
Molecular Cancer Therapeutics
|
October 22, 2017
Discovery of a Highly Selective NAMPT Inhibitor That Demonstrates Robust Efficacy and Improved Retinal Toxicity with Nicotinic Acid Coadministration
Genshi Zhao, Colin F Green, Yu-Hua Hui, et al.
Page
of 3